Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Hester

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Frontiers in Pediatrics|March 21, 2019
Modeling Human Brain Circuitry Using Pluripotent Stem Cell PlatformsAnnalisa M Hartlaub, Craig A McElroy, Nathalie L Maitre, et al.
Current Gene Therapy|October 29, 2009
AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALSMark E Hester, Kevin D Foust, Rita W Kaspar, et al.
Stem Cell Reviews and Reports|November 12, 2020
Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's diseaseLalitha Venkataraman, Summer R Fair, Craig A McElroy, et al.
Electrophoresis|July 2, 2014
Next-generation sequencing approach to epigenetic-based tissue source attributionCraig M Bartling, Mark E Hester, Julianne Bartz, et al.
Current Protocols|February 3, 2021
Generation of Neurosphere-Derived Organoid-Like-Aggregates (NEDAS) from Neural Stem CellsFumihiro Watanabe, Austin Schoeffler, Summer R Fair, et al.
Developmental Biology|April 1, 2026
The Role of Transcription-Coupled Nucleotide Excision Repair (TC-NER) during Mammalian Forebrain DevelopmentSmruti Patel, Morgan Moser, Natalie M Miller, et al.
Plos One|June 20, 2020
Brd2 haploinsufficiency extends lifespan and healthspan in C57B6/J miceShilpa Pathak, William C L Stewart, Christin E Burd, et al.
Pediatric Neurology|March 30, 2019
Gabapentin Use for Hospitalized NeonatesHibo H Abdi, Nathalie L Maitre, Kristen L Benninger, et al.
Plos One|September 19, 2009
Two factor reprogramming of human neural stem cells into pluripotencyMark E Hester, Sungwon Song, Carlos J Miranda, et al.
The CRISPR Journal|December 10, 2024
CRISPR-Cas9-Mediated Correction of <i>TSC2</i> Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 2Gongbo Guo, Morgan Moser, Lincoln Chifamba, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Pediatrics|March 21, 2019
Modeling Human Brain Circuitry Using Pluripotent Stem Cell PlatformsAnnalisa M Hartlaub, Craig A McElroy, Nathalie L Maitre, et al.
Current Gene Therapy|October 29, 2009
AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALSMark E Hester, Kevin D Foust, Rita W Kaspar, et al.
Stem Cell Reviews and Reports|November 12, 2020
Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's diseaseLalitha Venkataraman, Summer R Fair, Craig A McElroy, et al.
Electrophoresis|July 2, 2014
Next-generation sequencing approach to epigenetic-based tissue source attributionCraig M Bartling, Mark E Hester, Julianne Bartz, et al.
Current Protocols|February 3, 2021
Generation of Neurosphere-Derived Organoid-Like-Aggregates (NEDAS) from Neural Stem CellsFumihiro Watanabe, Austin Schoeffler, Summer R Fair, et al.
Developmental Biology|April 1, 2026
The Role of Transcription-Coupled Nucleotide Excision Repair (TC-NER) during Mammalian Forebrain DevelopmentSmruti Patel, Morgan Moser, Natalie M Miller, et al.
Plos One|June 20, 2020
Brd2 haploinsufficiency extends lifespan and healthspan in C57B6/J miceShilpa Pathak, William C L Stewart, Christin E Burd, et al.
Pediatric Neurology|March 30, 2019
Gabapentin Use for Hospitalized NeonatesHibo H Abdi, Nathalie L Maitre, Kristen L Benninger, et al.
Plos One|September 19, 2009
Two factor reprogramming of human neural stem cells into pluripotencyMark E Hester, Sungwon Song, Carlos J Miranda, et al.
The CRISPR Journal|December 10, 2024
CRISPR-Cas9-Mediated Correction of <i>TSC2</i> Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 2Gongbo Guo, Morgan Moser, Lincoln Chifamba, et al.
Pageof 4